An update on novel pharmacological agents for primary sclerosing cholangitis-Reference-Cited by-同舟云学术

An update on novel pharmacological agents for primary sclerosing cholangitis

Published:2022-01-02 Issue:1 Volume:26 Page:69-77
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Gallo Camilla¹²,Howardson Bright Oworae¹²,Cristoferi Laura¹²,Carbone Marco¹²,Gershwin M. Eric³,Invernizzi Pietro¹²^ORCID

Affiliation:

1. Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy

2. European Reference Network on Hepatological Diseases (Ern Rare-liver), San Gerardo Hospital, Monza, Italy

3. Division of Rheumatology and Clinical Immunology, University of California at Davis School of Medicine, Davis, California, USA

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2022.2030707

Reference70 articles.

1. Primary sclerosing cholangitis

2. Five Cases ofDe NovoInflammatory Bowel Disease After Orthotopic Liver Transplantation

3. Pathologic Features of Ulcerative Colitis in Patients With Primary Sclerosing Cholangitis

4. Genome-Wide Association Analysis in Primary Sclerosing Cholangitis

5. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of donor sex on the post-liver transplant outcomes in patients with primary sclerosing cholangitis;European Journal of Gastroenterology & Hepatology;2024-02-28

2. Clinical trials reimagined;Hepatology;2023-05-05

3. Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview;Nutrients;2023-02-02

4. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value;World Journal of Gastroenterology;2022-11-28

5. Primary sclerosing cholangitis—A long night's journey into day;Clinical Liver Disease;2022-11